Last update:

Gastroenterology news

TROP2 marks relapse-driving colorectal cancer cells and opens path to targeted treatment

A team led by researchers from the German Cancer Research Center (DKFZ) and the HI-STEM Stem Cell Institute has discovered a promising new approach to treating advanced colorectal cancer. The study, published in Nature, identifies ...

Fatty liver drives a more dangerous form of colorectal cancer spread, study reveals

Researchers at VIB and KU Leuven, with international partners, have uncovered how fatty liver disease can fuel the most aggressive form of metastatic colorectal cancer. The findings, which appear in the journal Nature, not ...

Breast milk gives certain gut bacteria a head start

Breast milk helps shape the gut microbiota for longer than previously thought. Researchers from DTU and Rigshospitalet have discovered that sugars in breast milk, which are nondigestible by the infant—so-called human milk ...

Blood test finds hidden pancreatic cancer after treatment

Northwestern Medicine scientists have demonstrated that a highly sensitive blood test can detect traces of pancreatic cancer missed by standard testing, potentially helping physicians identify patients whose disease is more ...

How inflammation may prime the gut for cancer

Chronic inflammation can raise a person's risk of cancer, and a new study reveals key details about how that might happen in the gut and points to better ways to identify and reduce risk. Scientists at the Broad Institute ...

Could a gut microbe influence muscle strength?

The trillions of microbes living in the human gut are increasingly recognized as important partners in human health. Scientists have linked the gut microbiome to several aspects of health, from metabolism and immunity to ...

What to know about fatty liver disease and why it's so common

Fatty liver disease is when too much fat builds up in the liver. The liver is the body's filter. It helps clean the blood, store energy and process nutrients. If too much fat stays in the liver, it can harm the organ and ...

Promising active substance against hepatitis E identified

Around 70,000 people die each year from infections with the hepatitis E virus. There is currently neither a vaccine nor a specific drug against this virus. This could change with the identification of bemnifosbuvir as a compound ...

Gut microbiome thrives on fiber—tapeworms confirm it

Intestinal worms can help reduce inflammation in the human body—but only if they have enough dietary fiber. Without it, they switch into a hibernation-like state and their protective effect disappears. This is the finding ...

Student shines a light on rare colon cancer

Colon cancer is one of the most common cancers in the U.S., with more than 100,000 cases diagnosed each year. But some people develop a highly aggressive form of colon cancer that is extremely rare, making up 0.02% to 0.1% ...